For US residents only

SARCLISA is a prescription medicine used in combination with pomalidomide and dexamethasone to treat adults who have received at least 2 prior therapies, including lenalidomide and a proteasome inhibitor, to treat multiple myeloma.

Proteasome inhibitors include medicines such as Kyprolis® (carfilzomib), Ninlaro® (ixazomib), and Velcade® (bortezomib).


CareASSIST by Sanofi Genzyme helps eligible patients with access and support for SARCLISA. Explore the services and resources available to help you get started and stay on track with SARCLISA.

If you have commercial insurance, you may be eligible for the CareASSIST Copay Program. If you qualify, your out-of-pocket costs may be as little as $0. Learn more.


Access and

CareASSIST can help determine insurance coverage and options.


Financial Assistance

CareASSIST offers programs and services that can help eligible patients with the cost of treatment.


Resource Support

CareASSIST can identify other resources and support that may be available.

To learn more about CareASSIST for SARCLISA, call 1-833-WE+CARE
(1-833-930-2273), Mon – Fri, 9 AM – 8 PM ET, or visit

Learn More

Get the latest updates about SARCLISA

There is much more information about SARCLISA coming soon. Register below to get the latest about SARCLISA as soon as it becomes available, including updates to this website and helpful resources.

All fields are required unless otherwise noted.